Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HMN | XERS |
|---|---|---|
| Price | $45.60 | $10.13 |
| Change today | ▲ 0.75% | ▲ 11.56% |
| Market cap | $1.85B | $1.85B |
| Return, 3 months | -14.7% | +13.3% |
| Return, year to date | +1.1% | +29.0% |
| Return, 1 year | +6.2% | +24.6% |
| P/E (TTM) | 10.7 | -104.4 |
| P/B | 1.2 | -191.1 |
| P/E percentile vs own 5y | 24th | 0th |
| Dividend yield | 3.11% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +18.4% | +14.5% |
| Analyst buy share | 100% | 80% |
| RSI (14) | 35 | 67 |
| 30-day volatility | 18.6% | 60.4% |
| Max drawdown, 1 year | -17.0% | -46.6% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
